rVSVΔG-ZEBOV-GP (also designated V920) recombinant vesicular stomatitis virus pseudotyped with Ebola Zaire Glycoprotein: Standardized template with key considerations for a risk/benefit assessment
Work
Year: 2019
Type: article
Abstract: The Brighton Collaboration Viral Vector Vaccines Safety Working Group (V3SWG) was formed to evaluate the safety and characteristics of live, recombinant viral vector vaccines. A recent publication by ... more
Source: Vaccine X
Authors Thomas P. Monath, Patricia Fast, Kayvon Modjarrad, David K. Clarke, Brian K. Martin +10 more
Institutions NewLink Genetics (United States), International AIDS Vaccine Initiative, Walter Reed Army Institute of Research, Profectus Biosciences (United States), Merck & Co., Inc., Rahway, NJ, USA (United States) +1 more
Cites: 117
Cited by: 78
Related to: 10
FWCI: 8.753
Citation percentile (by year/subfield): 99.99
Subfield: Infectious Diseases
Field: Medicine
Domain: Health Sciences
Sustainable Development Goal Good health and well-being
Open Access status: gold
APC paid (est): $1,800